Despite decades of digitization, healthcare still relies on fax machines, CDs and manual coordination to move patient information.
A seven-week dengue chain in LA County shows the continental US is closer to the threshold for tropical disease transmission than most people realize.
Why rare diseases like hantavirus generate fear while heart disease, loneliness, obesity, and poor sleep quietly cause far greater harm.
A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.
During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.
Most Americans support banning food dyes—but what drives diet quality is behavior, marketing and access. Removing dyes won’t fix what’s wrong with how we eat.
Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.
Longevity medicine seems to be the new shiny apple but how can it rewrite our health?
Editing a small number of blood-forming stem cells to encode powerful antibodies turns the immune system into a living drug factory.
In this week’s edition of InnovationRx, we look at the latest on the hantavirus outbreak, using quantum physics for metabolic MRIs, how AI can help fill prescriptions and more.